Pulike Biological Engineering Net Asset Quality Index
Pulike Biological Engineering net asset quality index. Pulike Biological Engineering (603566) has a Net Asset Quality Index of 83.4% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.09 Billion minus total liabilities of CN¥513.09 Million yields net assets of CN¥2.58 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Pulike Biological Engineering (603566) shareholders funds for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Pulike Biological Engineering (2009–2024)
Net asset quality index of Pulike Biological Engineering from 2009 to 2024. This chart shows how Pulike Biological Engineering's Net Asset Quality Index has evolved across 16 annual periods from 2009 to 2024. As of September 2025, the index stands at 83.4%, representing net assets of CN¥2.58 Billion against total assets of CN¥3.09 Billion CNY. Check Pulike Biological Engineering (603566) strategic asset index to assess the company's strategic physical and investment asset allocation.
Pulike Biological Engineering Net Asset Quality Index by Year (2009–2024)
Pulike Biological Engineering net asset quality index by year from 2009 to 2024. The table below presents the year-by-year Net Asset Quality Index for Pulike Biological Engineering from 2009 to 2024, covering 16 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 603566 stock market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 84.8% | CN¥2.63 Billion | CN¥3.10 Billion | CN¥471.11 Million | ▲ +1.3 pp |
| 2023 | 83.5% | CN¥2.72 Billion | CN¥3.26 Billion | CN¥538.33 Million | ▲ +0.9 pp |
| 2022 | 82.6% | CN¥2.80 Billion | CN¥3.39 Billion | CN¥588.07 Million | ▼ -0.4 pp |
| 2021 | 83.0% | CN¥1.80 Billion | CN¥2.17 Billion | CN¥367.83 Million | ▼ -1.2 pp |
| 2020 | 84.3% | CN¥1.71 Billion | CN¥2.03 Billion | CN¥319.16 Million | ▼ -2.7 pp |
| 2019 | 87.0% | CN¥1.66 Billion | CN¥1.91 Billion | CN¥247.42 Million | ▲ +1.1 pp |
| 2018 | 85.9% | CN¥1.64 Billion | CN¥1.90 Billion | CN¥267.51 Million | ▼ -1.0 pp |
| 2017 | 86.9% | CN¥1.57 Billion | CN¥1.81 Billion | CN¥236.27 Million | ▲ +1.6 pp |
| 2016 | 85.3% | CN¥1.48 Billion | CN¥1.74 Billion | CN¥255.91 Million | ▼ -3.7 pp |
| 2015 | 88.9% | CN¥1.34 Billion | CN¥1.50 Billion | CN¥166.49 Million | ▲ +7.3 pp |
| 2014 | 81.6% | CN¥683.59 Million | CN¥837.72 Million | CN¥154.14 Million | ▼ -1.0 pp |
| 2013 | 82.6% | CN¥603.33 Million | CN¥730.68 Million | CN¥127.35 Million | ▲ +6.9 pp |
| 2012 | 75.7% | CN¥440.47 Million | CN¥582.13 Million | CN¥141.66 Million | ▲ +13.5 pp |
| 2011 | 62.2% | CN¥311.26 Million | CN¥500.56 Million | CN¥189.31 Million | ▲ +17.8 pp |
| 2010 | 44.4% | CN¥195.88 Million | CN¥441.53 Million | CN¥245.65 Million | ▼ -32.0 pp |
| 2009 | 76.3% | CN¥249.06 Million | CN¥326.26 Million | CN¥77.19 Million | — |